General Information
Drug ID
DR01194
Drug Name
Cefotiam
Synonyms
(6R,7R)-7-[2-(2-Amino-thiazol-4-yl)-acetylamino]-3-[1-(2-dimethylamino-ethyl)-1H-tetrazol-5-ylsulfanylmethyl]-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-[[2-(2-amino-1,3-thiazol-4-yl)acetyl]amino]-3-[[1-(2-dimethylaminoethyl)tetrazol-5-yl]sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-{[(2-amino-1,3-thiazol-4-yl)acetyl]amino}-3-[({1-[2-(dimethylamino)ethyl]-1H-tetrazol-5-yl}sulfanyl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-{[(2-amino-1,3-thiazol-4-yl)acetyl]amino}-3-[({1-[2-(dimethylamino)ethyl]-1H-tetrazol-5-yl}thio)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7b-[2-(aminothiazol-4-yl)acetamido]-3-[[[1-(2-dimethylaminoethyl)-1h-tetrazol-5-yl]thio]methyl]ceph-3-em-4-carboxylic acid; 7beta-(2-amino-1,3-thiazol-4-yl)acetamido-3-[({1-[2-(dimethylamino)ethyl]-1H-tetrazol-5-yl}sulfanyl)methyl]-3,4-didehydrocepham-4-carboxylic acid; Abbott-48999; Aspil; Aspil (TN); CEFOTIAM HYDROCHLORIDE; CGP 14221E; CGP-14221-E; CTM; Cefotiam (INN); Cefotiam [INN:BAN]; Cefotiamum; Cefotiamum [INN-Latin]; Ceradolan; Haloapor; SCE-963
Drug Type
Small molecular drug
Indication Fungal infections [ICD11: 1F20-1F2Z] Approved [1]
Therapeutic Class
Antibiotics
Structure
3D MOL 2D MOL
Formula
C18H23N9O4S3
Canonical SMILES
CN(C)CCN1C(=NN=N1)SCC2=C(N3C(C(C3=O)NC(=O)CC4=CSC(=N4)N)SC2)C(=O)O
InChI
InChI=1S/C18H23N9O4S3/c1-25(2)3-4-26-18(22-23-24-26)34-7-9-6-32-15-12(14(29)27(15)13(9)16(30)31)21-11(28)5-10-8-33-17(19)20-10/h8,12,15H,3-7H2,1-2H3,(H2,19,20)(H,21,28)(H,30,31)/t12-,15-/m1/s1
InChIKey
QYQDKDWGWDOFFU-IUODEOHRSA-N
CAS Number
CAS 61622-34-2
Pharmaceutical Properties Molecular Weight 525.6 Topological Polar Surface Area 251
Heavy Atom Count 34 Rotatable Bond Count 10
Hydrogen Bond Donor Count 3 Hydrogen Bond Acceptor Count 13
XLogP
-2.4
PubChem CID
43708
PubChem SID
103401140 , 104343035 , 11466510 , 11467630 , 11486000 , 117600521 , 124766419 , 126670035 , 134224539 , 134338422 , 135006449 , 136054981 , 137006379 , 140253709 , 143261064 , 14763007 , 14836521 , 160963577 , 163693587 , 164788213 , 174549096 , 179150782 , 196394354 , 198976567 , 223676320 , 226515016 , 236431513 , 249865493 , 251912556 , 251916666 , 252073508 , 252358745 , 34709097 , 46506679 , 47662540 , 47811024 , 47885651 , 48334777 , 48415723 , 49699361 , 50050897 , 50124314 , 50998350 , 51091952 , 8178318 , 85547195 , 85788073
ChEBI ID
CHEBI:355510
TTD Drug ID
D0K3DQ
DT(s) Transporting This Drug OAT3 Transporter Info Organic anion transporter 3 Substrate [2]
References
1 Cefotiam was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019)
2 Adaptive responses of renal organic anion transporter 3 (OAT3) during cholestasis. Am J Physiol Renal Physiol. 2008 Jul;295(1):F247-52.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.